Esperion Therapeutics, Inc.·4

May 24, 4:13 PM ET

VITULLO NICOLE 4

4 · Esperion Therapeutics, Inc. · Filed May 24, 2024

Insider Transaction Report

Form 4
Period: 2024-05-23
VITULLO NICOLE
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2024-05-23+65,00065,000 total
    Exercise: $2.25Exp: 2034-05-23Common Stock (65,000 underlying)
Footnotes (1)
  • [F1]The awards vest in full on the earlier of (i) May 23, 2025 and (ii) the Issuer's next annual meeting of stockholders following May 23, 2024.

Documents

2 files